Search Saint Luke's

Liver Cancer

An Interventional Open-label Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma

Cancer Screening
The Vanguard Study: Testing a New Way to Screen for Cancer

Breast Cancer 
A Randomized, Open-Label, Phase 3 Study of Fulvestrant and CDK4/6 Inhibitors With or Without Gedatolisib as First-Line Treatment in Patients With HR-Positive and HER2-Negative Advanced Breast Cancer 

Meet Catherine Hamilton, experienced leader of Saint Luke's Hedrick and Wright Memorial Hospitals, delivering patient-centered, nationally recognized care. Learn more.

Saint Luke’s High-risk Breast Clinic delivers supplemental services for individuals who are at heightened risk for breast cancer. Through collaboration with the Hereditary Cancer Program at Saint Luke’s Cancer Institute, patients will meet with a genetic counselor to evaluate family history in identifying genetic risk factors.

The School of Diagnostic Medical Sonography program is an 18-month program that prepares you to be an entry-level diagnostic medical sonographer.

Thank you for requesting an information packet from Saint Luke’s Center for Surgical Weight Loss. Please complete the form below to receive a digital packet. Call 816-932-7900 if you have any questions.

Hundreds of patients enroll in these programs annually for a broad range of randomized trials and registry-based research studies, making the programs essential to the mission of Saint Luke’s Mid America Heart Institute.

Saint Luke’s Marion Bloch Neuroscience Institute features a strong clinical research program to ensure our patients have access to the most innovative and effective treatments. 

This form should be completed only if you have a scheduled procedure or a delivery at a Saint Luke’s facility. It does not schedule your appointment.